Ask AI

ETL QA Program Namees

This is description for ETL program in basic details tab

Share

Program Content

Activities

  • new pdf
    Testing New PDF
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 29, 2022

    Expires: June 02, 2028

  • testing co with checkboxssfssd b
    Testing Credit only with checkbox
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 06, 2023

    Expires: July 06, 2024

  • Hassan ICC Test for questions with follow up
    Hassan ICC Test for questions with follow up
    Case Challenge
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 22, 2023

  • Automation Testing Skip Logic
    Automation Testing Skip Logic
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 18, 2025

    Expires: August 18, 2026

  • ETL Credits Only Activity Skip logic Conditional
    ETL Credits Only Activity Skip logic Conditional
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2025

    Expires: August 19, 2026

  • test
    test
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 23, 2024

    Expires: April 23, 2025

  • ACTiconsult
    45-year-old male with RET-positive advanced NSCLC
    ACTiconsult
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 25, 2025

    Expires: September 30, 2026

  • Testing multimedia hotfix
    Testing multimedia hotfix 
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 06, 2025

    Expires: October 06, 2026

  • Scrom Multimedia  Player
    Scrom Multimedia  Player
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 28, 2025

    Expires: October 28, 2026

  • Testing specialty
    Testing specialty
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 31, 2024

    Expires: May 31, 2025

  • Transcript Test
    Transcript Test
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2024

  • Slide player testSlide player test
    Slide player test
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 10, 2024

    Expires: July 10, 2025

  • Multimedia Test with markers
    Multimedia Test with markers
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 07, 2024

  • Testing CME Passport Family Medicine and Internal Medicine
    Testing CME Passport Family Medicine and Internal Medicine
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 02, 2024

    Expires: October 02, 2025

  • Testing Slideset Accredited Automation
    Testing Slideset Accredited Automation
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2025

    Expires: January 24, 2026

Provided by

ProCE Banner
ProCE Banner

provided by text

Supporters

supporter statement text

Abbott Diabetes Care Inc.

Loxo Oncology subsidiary of Eli Lilly

Partners

AXDEV CCO ILP

ProCE Banner

IOIBD

ProCE Banner

Lilly

ProCE Banner

partner statement text

Accreditation

testing accreditation - group level

Additional Information

testing addtional information - group level

Instructions for Credit

testing cme info group level

Disclosure

Primary Author

Emmanuel S. Antonarakis, MBBCh

Professor
Department of Oncology and Urology
Johns Hopkins University
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI

Full Professor of Microbial Diseases
Director, Centre for Experimental Pathogen Host Research
School of Medicine
University College Dublin
Dublin, Ireland

Patrick W. Mallon, MB, BCh, PhD, FRACP, FRCPI: consultant/advisor/speaker: Gilead Sciences, ViiV Healthcare. Test test test

Jae H. Park, MD

Chief, Cellular Therapy Service
Attending Physician, Leukemia Service
Professor of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Jae H. Park, MD: consultant/advisor/speaker: Adaptive Technologies, AffyImmune, Allogene, Amgen, Artiva Biotherapeutics, Autolus, Be Biopharma, BeiGene, Bright Pharmaceuticals, Bristol Myers Squibb, Caribou Biosciences, Curocell, Galapagos, IN8Bio, Kite, Kura Oncology, Minerva, Novartis, Pfizer, Servier, Synthekine, Takeda.

Contributing Author

Scott Antonia, MD, PhD

Chair
Medical Oncologist
Department of Thoracic Oncology
Moffitt Cancer Center
Tampa, Florida

Testing scott

Frederick R. Appelbaum, MD

Professor and Head
Department of Medical Oncology
University of Washington Medical Center
Member and Director
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

testing frederick

Lauren M. Osborne, MD

(Program Chair)
Vice Chair for Clinical Research, Obstetrics & Gynecology
Weill Cornell Medicine
New York, New York

tesing lauren

Format

testing format - group level

Target Audience

testing target audience - group

Program Learning Goal

testing program learning goal

Learning Objectives

  • Optimize care for persons with or at risk of viral hepatitis that is reflective of new challenges from the COVID-19 pandemic